From the smallest biotech to the biggest pharmaceutical stock The Motley Fool's Market Check-Up covers the health-care sector's biggest headlines, hottest market movers, and Obamacare's ongoing rollout.
In this segment from Tuesday's episode, health-care analyst David Williamson looks into three big pieces of bad news for big pharma companies GlaxoSmithKline (GSK 0.13%), Sanofi (SNY 1.47%), and Pfizer (PFE 1.04%). David looks at one embattled drug from each of these three companies, and ranks just how bad the damage really is case by case.
Follow David on Twitter: @MotleyDavid.
